DXCM Common Stock · Transaction Jun 30, 2026 · Filed Jul 6, 2026 · $1,001 to $15,000
DexCom, Inc.
Veridion Score
BETAHIGH CONF · 6 of 6 factors measuredComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is DXCM moving today?
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
DXCM overview
Related filings and maps
Congress activity in DXCM
DXCM Common Stock · Transaction May 27, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
DXCM Common Stock · Transaction May 15, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
DXCM Common Stock · Transaction May 7, 2026 · Filed Jun 10, 2026 · $1,001 to $15,000
DexCom, Inc. - Common Stock · Transaction May 7, 2026 · Filed May 10, 2026 · $100,001 to $250,000
DXCM contract awards, year to date.
Public federal awards linked to this ticker.
DXCM lobbying filings, year to date.
Registered lobbying filings matched to DexCom, Inc..